Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution
Recruiting
Phase 1
Interventional Study
Congenital Myasthenic Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- The Foundation for Orthopaedics and Regenerative Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with Congenital Myasthenic Syndrome will be treated with Mesenchymal Stem Cell Exosome solution.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients will need a diagnosis of Congenital Myasthenic Syndrome by a licensed physician.
* Patients must be able to provide informed consent, or have a guardian who does.
* Patient must be able to travel to the site of treatment.
Exclusion Criteria:
* Patients will be exclu…
Contacts